Idea principal
In 60 women who had finished breast cancer treatment, 12 weeks of two supervised strength sessions a week plus a 10,000-step goal raised full-body muscular strength more than steps alone (0.718, 95% CI 0.361-1.074, P < 0.001, d = 1.04). Fitness, fatigue, mood and quality of life did not improve, and the trial was small.
Study design
Ensayo aleatorizado
Reading basis
Published abstract
Reading focus
Comparator & uncertainty
Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.
Pregunta de investigación
Breast cancer survivors often have lower strength, fatigue and low mood after treatment, and exercise is a promising way to help. The authors tested whether adding supervised resistance training to a home walking goal improves physical fitness, cancer-related fatigue, depressive symptoms, quality of life and life satisfaction.
Población y método
Parallel-group, outcome assessor-blinded randomized controlled trial (ISRCTN14601208) in 60 female breast cancer survivors who finished their core treatments within the previous 10 years. Using computer-generated simple randomization, 32 women were assigned to resistance training (two sessions a week for 12 weeks plus instructions to take at least 10,000 steps a day) and 28 to a control group (at least 10,000 steps a day only). Muscular strength was measured with electromechanical dynamometry; the primary outcome was a standardized full-body muscular strength score. Secondary outcomes were cardiorespiratory fitness, shoulder mobility, cancer-related fatigue, depressive symptoms, health-related quality of life (HRQoL) and life satisfaction, assessed at baseline and week 12. Analysis was by intention-to-treat.
Resultados
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1The standardized full-body muscular strength score, the primary outcome, increased more in the resistance group than in the control group (0.718; 95% CI 0.361-1.074; P < 0.001; Cohen's d = 1.04), a large effect.
- 2The gains were consistent for upper-body strength (0.727; 95% CI 0.294-1.160; P = 0.001; d = 0.87) and lower-body strength (0.709; 95% CI 0.324-1.094; P = 0.001; d = 0.96).
- 3There was no effect on cardiorespiratory fitness, shoulder flexion, cancer-related fatigue, depressive symptoms, HRQoL or life satisfaction.
- 4In the resistance group, 29 of 32 attended at least 75% of sessions; all 28 controls completed the trial. Sensitivity analyses confirmed the results.
Límites e incertidumbre
- 1Small trial of 60 women at a single time point of 12 weeks, so effects on fatigue and mood may have been missed and long-term benefit is unknown.
- 2Participants were not blinded to their group, and the questionnaire outcomes (fatigue, depression, HRQoL) are self-reported.
- 3Both groups were told to walk at least 10,000 steps a day, so the trial tests the added value of strength training, not exercise versus none.
- 4Survivors up to 10 years after treatment were included, so results may differ by time since treatment. This reading is based on the abstract only.
Relevancia práctica
For women who have completed breast cancer treatment, adding supervised strength sessions twice a week to a walking habit gave a large strength gain in 12 weeks, though it did not shift fatigue, mood or quality of life in this trial. Strength training programs after cancer should be planned with the oncology team or a qualified exercise professional.
Tus datos
Steps from a wearable track the home walking goal used here, and a training log of weights and repetitions tracks strength better than a watch does. Keep the same exercises and loads, and compare month to month rather than session to session.
Cómo interpretar la evidencia
Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.
Resumen estructurado de los autores English
El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.
Purpose
This study assessed the effects of 12-week supervised resistance training combined with home-based physical activity on physical fitness, cancer-related fatigue, depressive symptoms, health-related quality of life (HRQoL), and life satisfaction in female breast cancer survivors.
Methods
A parallel-group, outcome assessor-blinded, randomized controlled trial included 60 female breast cancer survivors who had completed their core treatments within the previous 10 years. Through computer-generated simple randomization, participants were assigned to resistance training (RTG; two sessions/week for 12 weeks plus instructions to undertake ≥ 10,000 steps/d) or control (CG; ≥ 10,000 steps/d only). Outcomes were evaluated at baseline and week 12. Muscular strength was assessed with electromechanical dynamometry. A standardized full-body muscular strength score was the primary outcome. Secondary outcomes included cardiorespiratory fitness, shoulder mobility, cancer-related fatigue, depressive symptoms, HRQoL, and life satisfaction.
Results
Thirty-two participants were assigned to RTG (29 achieved ≥ 75% attendance) and 28 to CG (all completed the trial). Intention-to-treat analyses revealed that the standardized full-body muscular strength score increased significantly in the RTG compared to the CG (0.718; 95% CI 0.361-1.074, P < 0.001, Cohen's d = 1.04). This increase was consistent for the standardized scores of upper-body (0.727; 95% CI 0.294-1.160, P = 0.001, d = 0.87) and lower-body (0.709; 95% CI 0.324-1.094, P = 0.001, d = 0.96) strength. There was no effect on cardiorespiratory fitness, shoulder flexion, cancer-related fatigue, depressive symptoms, HRQoL, or life satisfaction. The sensitivity analyses confirmed these results.
Conclusion
and implication for cancer survivors. In female breast cancer survivors who had completed their core treatments within the past 10 years, adding two weekly sessions of supervised resistance training to a prescription of home-based physical activity for 12 weeks produced a large increase in upper-, lower-, and full-body muscular strength, while other fitness components and patient-reported outcomes did not improve.
Trial registration number
ISRCTN14601208.
Fuentes y atribución
Effects of a 12-week supervised resistance training program, combined with home-based physical activity, on physical fitness and quality of life in female breast cancer survivors: the EFICAN randomized controlled trial.
Soriano-Maldonado A, Díez-Fernández DM, Esteban-Simón A, Rodríguez-Pérez MA, Artés-Rodríguez E, Casimiro-Artés MA, Moreno-Martos H, Toro-de-Federico A, Hachem-Salas N, Bartholdy C, Henriksen M, Casimiro-Andújar AJ.
Journal of cancer survivorship : research and practice · 2022-03-22
DOI: 10.1007/s11764-022-01192-1 ↗PubMed · 35314958 ↗Europe PMC · Licencia registrada: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada
Fuentes verificadas 2026-11-01
Guías prácticas
Leer en contexto
ACSM review of 137 reviews: resistance training works, and few programme details matter
The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.
Medicine & Science in Sports & Exercise
Nearly every resistance training plan beat no exercise; heavy loads led for strength
In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.
British Journal of Sports Medicine
Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes
Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.
British Journal of Sports Medicine
Protein supplements and weight training: small extra gains, smaller in older adults
Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.
British Journal of Sports Medicine

